130 related articles for article (PubMed ID: 37788511)
21. FIGO stage IB1 cervical carcinoma: Place and principles of brachytherapy.
Huertas A; Oldrini S; Nesseler JP; Courrech F; Rétif P; Charra-Brunaud C; Peiffert D
Cancer Radiother; 2017 Apr; 21(2):155-163. PubMed ID: 28233697
[TBL] [Abstract][Full Text] [Related]
22. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
23. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer).
Classe JM; Rauch P; Rodier JF; Morice P; Stoeckle E; Lasry S; Houvenaeghel G;
Gynecol Oncol; 2006 Sep; 102(3):523-9. PubMed ID: 16504274
[TBL] [Abstract][Full Text] [Related]
24. Effect of preoperative radiotherapy on stage IB2 and IIA2 cervical cancer: A retrospective cohort study.
Zhang T; Kong W; Li F; Song D; Liu T; Han C; Jiao S; Chen J
Int J Surg; 2016 Jun; 30():63-7. PubMed ID: 27084347
[TBL] [Abstract][Full Text] [Related]
25. Oncologic results and surgical morbidity of laparoscopic nerve-sparing radical hysterectomy in the treatment of FIGO stage IB cervical cancer: long-term follow-up.
Park NY; Chong GO; Hong DG; Cho YL; Park IS; Lee YS
Int J Gynecol Cancer; 2011 Feb; 21(2):355-62. PubMed ID: 21270616
[TBL] [Abstract][Full Text] [Related]
26. Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.
Chai Y; Wang T; Wang J; Yang Y; Gao Y; Gao J; Gao S; Wang Y; Zhou X; Liu Z
BMC Cancer; 2014 Feb; 14():63. PubMed ID: 24495453
[TBL] [Abstract][Full Text] [Related]
27. Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size ≤2 cm.
Chen X; Zhao N; Ye P; Chen J; Nan X; Zhao H; Zhou K; Zhang Y; Xue J; Zhou H; Shang H; Zhu H; Leanne VM; Yan X
Int J Gynecol Cancer; 2020 May; 30(5):564-571. PubMed ID: 32276941
[TBL] [Abstract][Full Text] [Related]
28. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
29. Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients.
Cetina L; González-Enciso A; Cantú D; Coronel J; Pérez-Montiel D; Hinojosa J; Serrano A; Rivera L; Poitevin A; Mota A; Trejo E; Montalvo G; Muñoz D; Robles-Flores J; de la Garza J; Chanona J; Jiménez-Lima R; Wegman T; Dueñas-González A
Ann Oncol; 2013 Aug; 24(8):2043-7. PubMed ID: 23609186
[TBL] [Abstract][Full Text] [Related]
30. Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy.
Zivanovic O; Alektiar KM; Sonoda Y; Zhou Q; Iasonos A; Tew WP; Diaz JP; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2008 Nov; 111(2):265-70. PubMed ID: 18774596
[TBL] [Abstract][Full Text] [Related]
31. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?
Kamelle SA; Rutledge TL; Tillmanns TD; Gould NS; Cohn DE; Wright J; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Aug; 94(2):249-55. PubMed ID: 15297159
[TBL] [Abstract][Full Text] [Related]
32. Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer.
Nama V; Angelopoulos G; Twigg J; Murdoch JB; Bailey J; Lawrie TA
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011478. PubMed ID: 30311942
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
[TBL] [Abstract][Full Text] [Related]
34. Preoperative high-dose-rate brachytherapy for high-risk early-stage cervical cancer: Long-term clinical outcome analysis.
Gauci PA; Kee DLC; Thamphya B; Schiappa R; Delotte J; Chand-Fouche ME; Hannoun-Levi JM
Brachytherapy; 2022; 21(3):273-282. PubMed ID: 35094933
[TBL] [Abstract][Full Text] [Related]
35. Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer.
Morice P; Rouanet P; Rey A; Romestaing P; Houvenaeghel G; Boulanger JC; Leveque J; Cowen D; Mathevet P; Malhaire JP; Magnin G; Fondrinier E; Berille J; Haie-Meder C
Oncologist; 2012; 17(1):64-71. PubMed ID: 22234626
[TBL] [Abstract][Full Text] [Related]
36. Values of three different preoperative regimens in comprehensive treatment for young patients with stage Ib2 cervical cancer.
Zhao YB; Wang JH; Chen XX; Wu YZ; Wu Q
Asian Pac J Cancer Prev; 2012; 13(4):1487-9. PubMed ID: 22799353
[TBL] [Abstract][Full Text] [Related]
37. Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea.
Kim SI; Lee M; Lee S; Suh DH; Kim HS; Kim K; Chung HH; No JH; Kim JW; Park NH; Song YS; Kim YB
Gynecol Oncol; 2019 Oct; 155(1):75-82. PubMed ID: 31383569
[TBL] [Abstract][Full Text] [Related]
38. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
[TBL] [Abstract][Full Text] [Related]
40. A prospective randomized controlled study on multiple neoadjuvant treatments for patients with stage IB2 to IIA cervical cancer.
Wen H; Wu X; Li Z; Wang H; Zang R; Sun M; Huang X; Zhang Z; Cai S
Int J Gynecol Cancer; 2012 Feb; 22(2):296-302. PubMed ID: 22274319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
